Sernova Biotherapeutics Inc (TSX:SVA)
Canada
· Delayed Price · Currency is CAD 0.170
0.00 (0.00%)
Apr 28, 2026, 2:57 PM EST
Sernova Biotherapeutics Employees
Sernova Biotherapeutics had 8 employees as of January 31, 2026. The number of employees did not change since the number was last reported on October 31, 2025.
Employees
8
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-1.55M CAD
Market Cap
61.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | 8 | 0 | - |
| Oct 31, 2025 | 8 | -9 | -52.94% |
| Oct 31, 2024 | 17 | - | - |
Sernova Biotherapeutics News
- 5 days ago - Sernova Biotherapeutics Announces Closing of Recently Approved Financings - Newsfile Corp
- 19 days ago - Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders - Newsfile Corp
- 5 weeks ago - Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing - Newsfile Corp
- 7 weeks ago - Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval - Newsfile Corp
- 2 months ago - Sernova Biotherapeutics Announces Warrant Amendments - Newsfile Corp
- 7 months ago - Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang - Newsfile Corp
- 7 months ago - Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors - TheNewswire
- 10 months ago - Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes - GlobeNewsWire